Circulating inhibitors of blood coagulation associated with procainamide-induced lupus erythematosus

✍ Scribed by Stephen Davis; Barbara C. Furie; John H. Griffin; Bruce Furie

• Publisher: John Wiley and Sons
• Year: 1978
• Tongue: English
• Weight: 493 KB
• Volume: 4
• Category: Article
• ISSN: 0361-8609
• DOI: 10.1002/ajh.2830040411

✦ Synopsis

We studied a patient being treated with procainamide in whom we observed a high antinuclear antibody titer and prolonged activated partial thromboplastin (PTT), prothrombin (PT), and Stypven times (ST). Serum antibody concentrations against single-stranded DNA were elevated while those aginst native DNA were not elevated, suggesting the procainamide-induced lupus syndrome. Dilution of the patient's plasma with normal plasma failed to correct the PTT and PT, indicating the presence of an inhibitor(s) to blood coagulation. The anticoagulant activity was associated with the IgG fraction of the patient's serum. Addition of purified or partially purified human factors IX, X, VIII, VII, XIa, prekallikrein, high molecular weight kininogen, or phospholipids to the patient's plasma failed to correct the PTT, PT, or ST; however, purified human factor XII and prothrombin corrected the PTT and ST, respectively. These results indicate that production of antibodies directed against antigenic determinants on coagulation proteins can be a manifestation of procainamide-induced lupus erythematosus.